257 related articles for article (PubMed ID: 33085017)
21. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.
Lazzaroni M; Bianchi Porro G
Dig Liver Dis; 2001 Dec; 33 Suppl 2():S44-58. PubMed ID: 11827362
[TBL] [Abstract][Full Text] [Related]
22. Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors.
Hirschowitz BI; Worthington J; Mohnen J
Aliment Pharmacol Ther; 2008 Jun; 27(11):1110-21. PubMed ID: 18315582
[TBL] [Abstract][Full Text] [Related]
23. Association between Acid-Lowering Agents, Metformin, and Vitamin B12 among Boston-Area Puerto Ricans.
Dinesh D; Lee JS; Scott TM; Tucker KL; Palacios N
J Nutr; 2023 Aug; 153(8):2380-2388. PubMed ID: 37302714
[TBL] [Abstract][Full Text] [Related]
24. Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis.
Choudhury A; Jena A; Jearth V; Dutta AK; Makharia G; Dutta U; Goenka M; Kochhar R; Sharma V
Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):479-487. PubMed ID: 37060552
[TBL] [Abstract][Full Text] [Related]
25. Combination drug therapy for gastroesophageal reflux disease.
Cross LB; Justice LN
Ann Pharmacother; 2002 May; 36(5):912-6. PubMed ID: 11978171
[TBL] [Abstract][Full Text] [Related]
26. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals.
den Elzen WP; Groeneveld Y; de Ruijter W; Souverijn JH; le Cessie S; Assendelft WJ; Gussekloo J
Aliment Pharmacol Ther; 2008 Mar; 27(6):491-7. PubMed ID: 18194503
[TBL] [Abstract][Full Text] [Related]
27. [Vitamin B12 deficiency and acid blockers - connection is there, causality remains unclear].
Markun S
Praxis (Bern 1994); 2014 Apr; 103(9):541-2. PubMed ID: 24755505
[No Abstract] [Full Text] [Related]
28. Is there any acid peptic disease that is refractory to proton pump inhibitors?
Bardhan KD
Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
[TBL] [Abstract][Full Text] [Related]
29. Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring.
Yitshak-Sade M; Gorodischer R; Aviram M; Novack L
J Clin Pharmacol; 2016 Jan; 56(1):116-23. PubMed ID: 26096778
[TBL] [Abstract][Full Text] [Related]
30. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations.
Koyyada A
Therapie; 2021; 76(1):13-21. PubMed ID: 32718584
[TBL] [Abstract][Full Text] [Related]
31. Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials.
Salas M; Ward A; Caro J
BMC Gastroenterol; 2002 Jul; 2():17. PubMed ID: 12119060
[TBL] [Abstract][Full Text] [Related]
32. Intravenous proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: determining statistical equivalence according to evidence-based methods.
Messori A; Fadda V; Maratea D; Gatto R; Trippoli S; De Rosa M; Marinai C
Int J Clin Pharmacol Ther; 2014 Oct; 52(10):825-9. PubMed ID: 25074869
[TBL] [Abstract][Full Text] [Related]
33. A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations.
Blanco Dorado S; Maroñas Amigo O; Latorre-Pellicer A; Rodríguez Jato MT; López-Vizcaíno A; Gómez Márquez A; Bardán García B; Belles Medall D; Barbeito Castiñeiras G; Pérez Del Molino Bernal ML; Campos-Toimil M; Otero Espinar F; Blanco Hortas A; Zarra Ferro I; Carracedo Á; Lamas MJ; Fernández-Ferreiro A
Br J Clin Pharmacol; 2020 Aug; 86(8):1661-1666. PubMed ID: 32110830
[TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway.
Hamano H; Niimura T; Horinouchi Y; Zamami Y; Takechi K; Goda M; Imanishi M; Chuma M; Izawa-Ishizawa Y; Miyamoto L; Fukushima K; Fujino H; Tsuchiya K; Ishizawa K; Tamaki T; Ikeda Y
Toxicol Lett; 2020 Jan; 318():86-91. PubMed ID: 31669099
[TBL] [Abstract][Full Text] [Related]
35. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
Xue S; Katz PO; Banerjee P; Tutuian R; Castell DO
Aliment Pharmacol Ther; 2001 Sep; 15(9):1351-6. PubMed ID: 11552905
[TBL] [Abstract][Full Text] [Related]
36. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
37. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Vitamin B12 Monitoring in Patients on Concomitant Metformin and Proton Pump Inhibitors.
Chappell L; Brown SA; Wensel TM
Innov Pharm; 2020; 11(4):. PubMed ID: 34007643
[TBL] [Abstract][Full Text] [Related]
39. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Caro JJ; Salas M; Ward A
Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
[TBL] [Abstract][Full Text] [Related]
40. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
